GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theriva Biologics Inc (FRA:SFY) » Definitions » Other Current Liabilities

Theriva Biologics (FRA:SFY) Other Current Liabilities : €0.61 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Theriva Biologics Other Current Liabilities?

Theriva Biologics's other current liabilities for the quarter that ended in Mar. 2024 was €0.61 Mil.

Theriva Biologics's quarterly other current liabilities declined from Sep. 2023 (€0.19 Mil) to Dec. 2023 (€0.12 Mil) but then increased from Dec. 2023 (€0.12 Mil) to Mar. 2024 (€0.61 Mil).

Theriva Biologics's annual other current liabilities increased from Dec. 2021 (€-0.00 Mil) to Dec. 2022 (€2.89 Mil) but then declined from Dec. 2022 (€2.89 Mil) to Dec. 2023 (€0.12 Mil).

Theriva Biologics Other Current Liabilities Historical Data

The historical data trend for Theriva Biologics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theriva Biologics Other Current Liabilities Chart

Theriva Biologics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Theriva Biologics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Theriva Biologics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Theriva Biologics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Theriva Biologics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Theriva Biologics (FRA:SFY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theriva Biologics Inc (FRA:SFY) » Definitions » Other Current Liabilities
Comparable Companies
ADIL GTBP PRTG FRTX SILO PCSA SONN LIXT AZTR SNPX OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
TOVX:USA
Address
9605 Medical Center Drive, Suite 270, Rockville, MD, USA, 20850
Website
https://www.therivabio.com
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Theriva Biologics (FRA:SFY) Headlines

From GuruFocus

SOFI WEALTH, LLC Goes on Buying Spree in 2nd Quarter

By GuruFocus Research GuruFocus Editor • 07-25-2022

SoFi Releases SoFi Gig Economy ETF (GIGE) and SoFi 50 ETF (SFYF)

By PRNewswire PRNewswire • 05-08-2019